Chitose key facts
- Developer of biotechnology-based technologies intended to build a sustainable global bioeconomy.
- It has raised $82.8M; the latest was Later Stage VC ($48.5M) in Mar 2025.
- Notable investors include Mizuho Bank, Sumitomo Mitsui Trust Bank, Sumitomo Mitsui Banking Corporation, Jafco Investment (Asia Pacific), NSK Investment Partners — 22 tracked in total.
- Status: Privately Held (backing).
Who backs Chitose
22+- ·The complete investor list: 22 names
- ·Watch Chitose: the Monday email on marks, rounds and moves
Chitose funding rounds
No funding rounds for Chitose are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Chitose investors
22 investors are on record for Chitose, including Mizuho Bank, Sumitomo Mitsui Trust Bank, Sumitomo Mitsui Banking Corporation and Jafco Investment (Asia Pacific).
About Chitose
Developer of biotechnology-based technologies intended to build a sustainable global bioeconomy. The company offerswide range of technologies based on microorganisms, algae, and mammalian cells and utilizes these technologies for industrial use of the organism, enabling global markets to transition toward a bioeconomy that supports human life.
- Sector
- Healthcare
- HQ
- Singapore, Singapore
- Founded
- 2002
- Employees
- 100
- Website
- chitose-bio.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Chitose doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.